Clinical Trial Update: The Effect of Human Recombinant Erythropoietin in Acute Renal Failure [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effect of human recombinant erythropoietin in acute kidney injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)

Snippet

Sponsor: North Texas Veterans Healthcare System | Conditions: Acute Kidney Injury | Phase 2 | Status: COMPLETED